The Enterprise Value as of December 2025 (TTM) for Windlas Biotech Limited (WINDLAS.NS) is 16.43B

According to Windlas Biotech Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 16.43B. This represents a change of -19.18% compared to the average of 20.33B of the last 4 quarters.

Windlas Biotech Limited (WINDLAS.NS) Historical Enterprise Value (quarterly & annually)

How has WINDLAS.NS Enterprise Value performed in the past?

The mean historical Enterprise Value of Windlas Biotech Limited over the last ten years is 9.15B. The current 16.43B Enterprise Value has changed 17.86% with respect to the historical average. Over the past ten years (40 quarters), WINDLAS.NS's Enterprise Value was at its highest in in the December 2024 quarter at 21.77B. The Enterprise Value was at its lowest in in the September 2020 quarter at 0.

Windlas Biotech Limited (WINDLAS.NS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Windlas Biotech Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Windlas Biotech Limited (WINDLAS.NS) Average Enterprise Value

How has WINDLAS.NS Enterprise Value performed in the past?

The current Enterprise Value of Windlas Biotech Limited (WINDLAS.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Windlas Biotech Limited (WINDLAS.NS) Enterprise Value vs. Peers

How is WINDLAS.NS’s Enterprise Value compared to its peers?

Windlas Biotech Limited’s Enterprise Value is less than Amrutanjan Health Care Limited (19.00B), less than Amrutanjan Health Care Limited (19.00B), greater than Novartis India Limited (13.23B), greater than Syncom Formulations (India) Limited (14.23B), greater than Syncom Formulations (India) Limited (14.23B), greater than Bajaj HealthCare Limited (15.49B), greater than Bajaj HealthCare Limited (15.49B), less than Bliss GVS Pharma Limited (16.67B), greater than Megasoft Limited (14.39B), less than Bliss GVS Pharma Limited (16.67B),

Build a custom stock screener for Windlas Biotech Limited (WINDLAS.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Windlas Biotech Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Windlas Biotech Limited (WINDLAS.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Windlas Biotech Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.